US Stock MarketDetailed Quotes

RXRX Recursion Pharmaceuticals

Watchlist
  • 6.950
  • -0.030-0.43%
Close Dec 13 16:00 ET
  • 7.000
  • +0.050+0.72%
Post 20:01 ET
1.99BMarket Cap-4.51P/E (TTM)

Recursion Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Recursion Pharmaceuticals Q3 2024 Earnings Date

Currency：USDNov 6, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
29.83M
26.08M
-3.75M
Miss Est.
+183.19%
+147.62%
-12.56%
EPS
-0.35
-0.34
+0.01
Beat Est.
+18.49%
+20.93%
+2.97%
Analyst Rating
Buy

Dec 13, 2024

Recursion Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 12.975M--
--2024/Q4-- / 18.171M--
Nov 6, 20242024/Q326.082M / 29.829M--
Aug 8, 20242024/Q214.417M / 13.286M--
May 9, 20242024/Q113.794M / 13.067M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 12.975M--
--2024/Q4-- / 18.171M--
Nov 6, 20242024/Q326.082M / 29.829M--
Aug 8, 20242024/Q214.417M / 13.286M--
May 9, 20242024/Q113.794M / 13.067M--

Unlock Free Earnings Estimates

Recursion Pharmaceuticals Earnings Reports

  • Recursion Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 6 16:23 ET

  • Recursion Pharmaceuticals | 8-K: Recursion Provides Business Updates and Reports Third Quarter 2024 Financial Results

    Nov 6 16:22 ET

  • Recursion Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 8 08:14 ET

  • Recursion Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 9 16:22 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 13, 2024

    Buy

    • Buy

      40.00%

    • Hold

      60.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme NVIDIA Portfolio
    NVIDIA Portfolio
    Intraday+3.21%